OliX Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	17,283	3,883	11,983	4,930	34,337	11,329
Short-Term Investments	91,900	-	10,000	53,000	15,000	55,000
Trading Asset Securities	22,272	8,531	3,942	3,941	420.68	1,782
Cash & Short-Term Investments	131,455	12,414	25,925	61,872	49,757	68,111
Cash Growth	1007.85%	-52.11%	-58.10%	24.35%	-26.95%	91.64%
Accounts Receivable	28.58	0	3,558	53.23	-	-
Other Receivables	599.5	907.84	1,419	996.88	272.13	159.18
Receivables	628.08	907.84	4,977	1,050	491.49	446.57
Inventory	455.77	554.26	468.41	657.17	374.13	304.17
Prepaid Expenses	1,316	1,370	244.9	1,367	1,480	7.13
Other Current Assets	42.5	287.98	526.86	99	136.92	178.26
Total Current Assets	133,898	15,534	32,142	65,046	52,240	69,047
Property, Plant & Equipment	49,495	51,385	43,910	37,232	31,525	6,180
Long-Term Investments	796.77	1,986	23,481	26,809	0.5	0.45
Other Intangible Assets	1,929	1,705	1,981	2,107	2,134	2,529
Other Long-Term Assets	461.29	639.62	1,312	1,458	772.05	820.53
Total Assets	186,580	71,249	102,825	132,651	86,672	78,577
Accrued Expenses	301.33	488.52	465.36	358.62	297.85	80.04
Short-Term Debt	644	13,441	-	-	-	-
Current Portion of Long-Term Debt	3,571	3,572	-	19,230	16,405	-
Current Portion of Leases	185.81	745.85	1,065	939.87	487.8	258.63
Current Income Taxes Payable	6.42	53.77	-	-	-	-
Other Current Liabilities	12,883	11,759	5,033	19,014	23,174	4,150
Total Current Liabilities	17,592	30,060	6,563	39,543	40,365	4,488
Long-Term Debt	18,750	21,428	35,362	20,000	20,326	14,011
Long-Term Leases	-	5.38	2,930	3,826	51.69	257
Pension & Post-Retirement Benefits	1,005	414.47	-	-	225.41	225.59
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,647
Other Long-Term Liabilities	6,675	867.98	7,634	3,080	6,296	12,597
Total Liabilities	44,022	52,777	52,489	66,449	67,265	33,227
Common Stock	10,057	9,230	8,010	6,852	6,852	6,771
Additional Paid-In Capital	330,680	175,533	157,177	151,895	92,908	91,128
Retained Earnings	-206,045	-167,785	-122,910	-103,224	-84,303	-54,379
Comprehensive Income & Other	6,195	871.87	7,141	8,885	3,064	1,765
Total Common Equity	140,888	17,849	49,418	64,407	18,521	45,286
Minority Interest	681.25	623.76	481.45	295.16	886.27	65.31
Shareholders' Equity	142,559	18,473	50,336	66,203	19,407	45,351
Total Liabilities & Equity	186,580	71,249	102,825	132,651	86,672	78,577
Total Debt	23,151	39,192	39,357	43,996	37,271	14,527
Net Cash (Debt)	108,304	-26,778	-13,433	17,876	12,487	53,584
Net Cash Growth	-	-	-	43.16%	-76.70%	51.72%
Net Cash Per Share	5703.61	-1589.86	-930.93	1304.50	912.36	4074.15
Filing Date Shares Outstanding	20.11	18.46	16.02	13.7	13.7	13.54
Total Common Shares Outstanding	20.11	18.46	16.02	13.7	13.7	13.54
Working Capital	116,306	-14,526	25,578	25,502	11,874	64,559
Book Value Per Share	7004.20	966.92	3084.79	4700.19	1351.59	3344.07
Tangible Book Value	138,958	16,144	47,437	62,300	16,387	42,756
Tangible Book Value Per Share	6908.27	874.55	2961.16	4546.39	1195.84	3157.30
Land	25,325	25,460	25,740	25,740	25,740	988.21
Buildings	22,687	23,033	3,354	3,354	3,354	3,115
Machinery	7,468	7,425	6,436	5,518	4,427	3,330
Construction In Progress	25.8	-	8,948	1,239	71.73	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.